Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. (Q54689960)

2 June 2018

title

Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. (English)

1 reference

2 June 2018

Olivier Cussenot

5

0 references

Morgan Rouprêt

2

object named as

Morgan Rouprêt

1 reference

2 June 2018

author name string

Sylvia Scarpini

1

1 reference

2 June 2018

Raphaële Renard-Penna

3

1 reference

2 June 2018

Philippe Camparo

4

1 reference

2 June 2018

Eva Compérat

6

1 reference

2 June 2018

publication date

2 March 2010

1 reference

2 June 2018

published in

Urologic Oncology

1 reference

2 June 2018

volume

30

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

182-187

1 reference

2 June 2018

Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

p53 function and dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Ki67 protein: the immaculate deception?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Tissue Microarray Analysis of the Prognostic Value of E-Cadherin, Ki67, p53, p27, Survivin and MSH2 Expression in Upper Urinary Tract Transitional Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Aurora kinases in spindle assembly and chromosome segregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Centrosome Hyperamplification and Chromosomal Instability in Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Amplification/overexpression of a mitotic kinase gene in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.003

10.1016/J.UROLONC.2009.12.003

7 January 2021

Identifiers

DOI

1 reference

2 June 2018

PubMed ID

20189840

1 reference

2 June 2018